Skip to end of metadata
Go to start of metadata

You are viewing an old version of this content. View the current version.

Compare with Current View Version History

« Previous Version 29 Next »

Click on the paperclip at the top of the page to add, remove or edit files. If possible, please add a row to the table below to allow easy access to your slides.

List of past meetings:

9 May 2012

PUW1

Joanna

Immunology

16 May 2012

WCJ

Angelina

Zidovudine PK/PG

23 May 2012

PUW2

Jig

LMWH in pregnancy

30 May 2012

No meeting

 

 

6 June 2012

PUW1

Joe

Antimicrobial PKPD

13 June 2012

PUW1

Terry Shepard

Geriatric PKPD

20 June 2012

PUW2

Rollo/Joanna

Immunology modelling

27 June 2012

No meeting

 

 

4th July 2012

No meeting

 

 

11th July 2012

PUW2

Julie

PAGE review

18th July 2012

PUW2

Katie

Gentamicin in burns

12/10/12 1pm

WCA

Rollo

Modelling of the immune reconstitution post BMT

19/10/12 1pm

PUW3

Joe

Prague Biometrics 2012;68:902-11

26/10/12 1pm

PUW3

Charlotte

NAPPA (Beta lactam pharmacokinetics/pharmacodynamics) plans

2/11/12 1pm

PUW3

Eva

Neogent (developing Bayesian therapeutic drug monitoring) progress

9/11/12 1pm

PUW3

Joanna

Inference methods course review

16/11/12 1pm

PUW2

 

General discussion

23/11/12 1pm

PUW3

Julie

Covariate selection methods in pharmacokinetic modelling

30/11/12 1pm

PUW3

Julie

NCA versus modelling in phase I studies for drugs with long half-life

7/12/12 1pm

PUW3

 

Goldacre talk

14/12/12 1pm

PUW3

Lilia

Neutropenia post-BMT

4/1/13 1pm

PUW3

 

General discussion

11/1/13 1pm

Levinsky

Joe

Maraviroc PK

18/1/13 1pm

PUW4

Andrezj

PKPD bridging of response between adults and children

25/1/13 1pm

PUW3

Lilia

Neutropenia following paediatric BMT

1/2/13 1pm

PUW1

Mirjam Trame

Use of PKPD modeling to guide HIV understanding and treatment

8/2/13 1pm

PUW3

Sami

Bioequivalence studies and genetic variability

15/2/13 1pm

PUW1

Liana

ErbB inhibition for PKD

22/2/13 1pm

PUW3

Alienor Berges (GSK)

 

1/3/13 1pm

PUW4

Rollo

CD4 reconstitution post BMT 

8/3/13 1pm

PUW3

Eva

Neogent update

15/3/13 1pm

PUW4

Tafi

Dose individualisation in HIV/AIDS and TB patients on Efavirenz (EFV).

22/3/13 1pm

PUW3

Hui Ma

Genetic components to glucose-insulin response

  • No labels